1. Home
  2. DHX vs PRLD Comparison

DHX vs PRLD Comparison

Compare DHX & PRLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo DHI Group Inc.

DHX

DHI Group Inc.

HOLD

Current Price

$1.59

Market Cap

81.1M

ML Signal

HOLD

Logo Prelude Therapeutics Incorporated

PRLD

Prelude Therapeutics Incorporated

HOLD

Current Price

$1.71

Market Cap

69.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DHX
PRLD
Founded
1991
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Business Services
Medicinal Chemicals and Botanical Products
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
81.1M
69.1M
IPO Year
2007
2020

Fundamental Metrics

Financial Performance
Metric
DHX
PRLD
Price
$1.59
$1.71
Analyst Decision
Buy
Strong Buy
Analyst Count
2
3
Target Price
$4.75
$4.00
AVG Volume (30 Days)
283.2K
405.6K
Earning Date
11-10-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$131,236,000.00
$10,500,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
250.00
52 Week Low
$1.21
$0.61
52 Week High
$3.34
$4.22

Technical Indicators

Market Signals
Indicator
DHX
PRLD
Relative Strength Index (RSI) 32.13 54.14
Support Level $1.69 $1.30
Resistance Level $1.92 $1.72
Average True Range (ATR) 0.08 0.16
MACD -0.01 0.02
Stochastic Oscillator 15.58 97.65

Price Performance

Historical Comparison
DHX
PRLD

About DHX DHI Group Inc.

DHI Group Inc is a provider of artificial intelligence-powered software products, online tools and services to deliver career marketplaces to candidates and employers globally. DHI's brands includes Dice and Clearance Jobs enable recruiters and hiring managers to efficiently search, match and connect with skilled technologists in specialized fields, particularly technology and those with active government security clearances. The company derive the majority of revenue came from the sale of recruitment packages, which allow customers to promote jobs on websites and source candidates through their resume databases. Recruitment packages are typically provided through contractual arrangements with annual, quarterly or monthly payment terms.

About PRLD Prelude Therapeutics Incorporated

Prelude Therapeutics Incorp is a clinical stage precision oncology company focused on discovering and developing small molecule therapies optimized to target the key driver mechanisms in cancers with high unmet needs. The company's pipeline includes four candidates currently in clinical development: PRT1419, a potent, selective inhibitor of MCL1; PRT2527, a potent and selective CDK9 inhibitor, PRT3645, a next-generation CDK4/6 inhibitor, and PRT3789 a first-in-class SMARCA2/BRM protein degrader.

Share on Social Networks: